Standardized Microbiota Transplant Therapy in Crohn s Disease.

Brief description of study

This study aims to examine the relationship between the intestinal microbiota and Crohn’s disease (CD) phenotype, and to evaluate whether modifying the microbiota can reduce intestinal inflammation in CD. Specifically, the study will compare two types of Microbiota Transplant Therapy (MTT) capsules to determine whether they differ in their ability to restore healthy gut microbes in individuals with Crohn’s disease.

Clinical Study Identifier: s25-01512

ClinicalTrials.gov Identifier: NCT06631586

Principal Investigator: Jordan E Axelrad.

Other Investigators: Elie S Al Kazzi, Shannon Chang, Adam Faye, Simon J Hong, Ariela Holmer, Lindsay Clarke, David P Hudesman.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies